44

Click here to load reader

Rational choice of inotropes and vasopressors in intensive care unit

Embed Size (px)

Citation preview

Page 1: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

INOTROPES

VASOPRESSORS

R A T I O N A L E O F C H O I C E

SANEESH P JSultan Qaboos University Hospital Muscat

inotropes vasopressors

INOTROPES

VASOPRESSORS

SHOCK

SEPSIS

CARDIAC FAILURE

VASST

NOREPINEPHRINE

DOBUTAMINE

DOPAMINE

RENAL DOSE

HYPOVOLEMIA

RECEPTORS

LEVOSIMENDAN

CATECHOLAMINES

PHENYLEPHRINE

VASOPRESSIN

inotropes vasopressors

INOTROPES amp VASOPRESSORSBasics

Patient ndash clinical features

Pathophysiology

Monitoring

Equipments

Drugs

Shock

CO SV

SVR

Preload

Afterload

inotropes vasopressors

Fundamentals

Volume status

One drugMany receptors

Dose responsecurve

Direct Vs Reflex

actions

inotropes vasopressors

Hemodynamics in Shock

Hypotension

Low SVR(arteriolar tone)

Low CO

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 2: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

INOTROPES

VASOPRESSORS

SHOCK

SEPSIS

CARDIAC FAILURE

VASST

NOREPINEPHRINE

DOBUTAMINE

DOPAMINE

RENAL DOSE

HYPOVOLEMIA

RECEPTORS

LEVOSIMENDAN

CATECHOLAMINES

PHENYLEPHRINE

VASOPRESSIN

inotropes vasopressors

INOTROPES amp VASOPRESSORSBasics

Patient ndash clinical features

Pathophysiology

Monitoring

Equipments

Drugs

Shock

CO SV

SVR

Preload

Afterload

inotropes vasopressors

Fundamentals

Volume status

One drugMany receptors

Dose responsecurve

Direct Vs Reflex

actions

inotropes vasopressors

Hemodynamics in Shock

Hypotension

Low SVR(arteriolar tone)

Low CO

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 3: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

INOTROPES amp VASOPRESSORSBasics

Patient ndash clinical features

Pathophysiology

Monitoring

Equipments

Drugs

Shock

CO SV

SVR

Preload

Afterload

inotropes vasopressors

Fundamentals

Volume status

One drugMany receptors

Dose responsecurve

Direct Vs Reflex

actions

inotropes vasopressors

Hemodynamics in Shock

Hypotension

Low SVR(arteriolar tone)

Low CO

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 4: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Fundamentals

Volume status

One drugMany receptors

Dose responsecurve

Direct Vs Reflex

actions

inotropes vasopressors

Hemodynamics in Shock

Hypotension

Low SVR(arteriolar tone)

Low CO

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 5: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Hemodynamics in Shock

Hypotension

Low SVR(arteriolar tone)

Low CO

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 6: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Hemodynamics in Shock

bull Inadequate CObull Comp vasoconstrictionbull Elevated SVR

COLD SHOCK

bull Inadequate SVRbull Pathologic vasodilatationbull Comp elevated CO

WARM SHOCK

Fluid resuscitation

Myocardial dysfunction

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 7: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Planning your strategy

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 8: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Adrenergic receptors and vasoactive agents

α βα =β

EpinephrinePhenylephrine Norepinephrine

Dopamine

IsoproterenolDobutamine

EpinephrinePhenylephrine

Norepinephrine

DopamineIsoproterenol

Dobutamine

High dose Low dose

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 9: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 10: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Direct inotropic effectsPe

riphe

ral v

ascu

lar e

ffect

sYESNO

Vaso

dila

tatio

nVa

soco

nstri

ctio

n

INOTROPES

VAS

OP

RE

SS

OR

S

Inoconstrictors

NorepinephrineEpinephrineDopamine

Inodilators

DobutamineMilrinone

Vasoconstrictors

PhenylephrineVasopressin

Vasodilators

NitroglycerineNitroprusside

Nesiritide

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 11: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Vasoconstriction

Vasodilation

PositiveInotropy

Vasopressin

PhenylephrineNorepinephrine

LD EpinephrineDopamine

Dobutamine

HD Dopamine

HD Epinephrine

Nitroprusside

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 12: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 13: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

HOW DO I MAKE MY CHOICE

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 14: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Rationale of choice

EFFECTSAGENTS

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 15: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Rationale of choice

Vasopressor Rx

Restoration of adequate BP

BP does NOT always equate to blood flow

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 16: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Rationale of choice

Inotrope Rx

IncreaseCardiac Output

To determine whether CO is adequate in patients with shock is a thorny problem

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 17: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Hypotension ndash reduced perfusion pressure

Abnormal shunting of blood flow within organs

Cellular alterations ndash inability to use delivered substrates

Down-regulation of adrenergic receptors

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 18: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Volume status

Vasopressors Inotropes

Monitors

bull Restore effective tissue perfusionbull Normalise cellular metabolism

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 19: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Decision makingbull Which one worksbull Sequencebull Mechanism of action == goals of therapybull Consider the best available clinical evidence

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 20: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

1CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 21: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

INOTROPESVASOPRESSORS

Ventricular arrhythmiasContraction- band necrosisInfarct expansion

Compromised myocardial perfusionElevated LV filling pressuresIncreased myocardial O2 reqrmtFurther reduction in CPP

Criticalhypotension

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 22: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 23: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP 70-100mmHgNo SS of Shock SS of Shock +

DOBUTAMINE DOPAMINE

Moderate doses of these agents maximize inotropy and avoid excessive 1113090α1-adrenergic stimulation that can result in end-organ ischemia

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 24: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

+ antithrombotic effects

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 25: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

SBP lt70 mmHgInadequate response to medium dose DOPAMINE or DOPAMINEDOBUT

Promote thrombosis in coronary vasculatureExacerbate lactic acidosis

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 26: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

CARDIOGENIC SHOCK COMPLICATING ACUTE MYOCARDIAL INFARCTION

NOREPINEPHRINE-resistant vasodilatory shock

Improve MAP Cardiac indexLV stroke workReduce NorEpi doseImprove Coronary blood flow (catecholamine sparing)

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 27: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

2NEUROCRITICAL CARE

TRAUMATIC BRAIN INJURY

ACUTE NEUROLOGIC INJURY

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 28: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Although high-quality clinical data are scarce the available evidence

suggests that NOREPINEPHRINE should be considered as the

vasopressor of choice when BP elevation is indicated in patients with

acute neurologic injury

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 29: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

September 2008 - Volume 36 - Issue 9 - pp 2641-2650doi 101097CCM0b013e3181847af3

After 2hrs of resuscitation of TBI phenylephrine or arginine vasopressin was titrated to cerebral perfusion pressure gt70 mm Hg (randomized and blinded) plus normal saline to maintain filling pressure gt12 mm Hg plus glucose to maintain normoglycemia

Vasopressin Phenylephrine

ICP

Brain tissue PO2

Peripheral tissue PO2

+10mmHg

+6mmHg

+10

AFTER 6 HRS

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 30: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

3SEVERE SEPSIS SHOCK

Surviving Sepsis Campaign International guidelines for management of severe sepsis and septic shock Intensive Care Med 2013 39(2) 165-228 and Crit Care Med 2013 41(2) 580- 637

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 31: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

SEVERE SEPSIS SHOCK

Vasopressor therapy initially to target MAP 65mmHg

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 32: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Improves systemic blood pressure bull Does not substantially worsen end-organ ischemia in

most studies of crystalloid-resuscitated septic shock patients

bull Equivalent efficacy in increasing mean arterial pressure oxygen consumption and oxygen delivery

compared with other catecholamine pressorsbull Gastric pH has been observed to increase (not

decrease)

First choice vasopressor

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 33: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull Epinephrine is added to and potentially substituted for NE when an additional agent is

needed to maintain adequate MAP

bull DOPAMINE is an alternative agent to NE only in highly selected patients (eg patients with low risk of tachyarrhythmias and absolute or

relative bradycardia)

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 34: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull NOT recommended in the Rx of shock except

a) NE associated with serious arrhythmias

b) CO is known to be high and BP persistently low

c) As salvage Rx when combined

inotropevasopressor drugs and low dose

vasopressin have failed to achieve MAP target

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 35: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

SEVERE SEPSIS SHOCK

bull VP 003Umin can be added to NE with intent of

either raising MAP or decreasing NE dosage

bull Low dose VP is NOT recommended as the single

initial vasopressor

bull VP doses higher than 003-004Umin should be

reserved for salvage Rx

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 36: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

bull 778 patients with septic shock randomly assigned to either low dose vasopressin (001 to 003 units per minute) norepinephrine (5 to 15 mcg per minute)

bull similar 28-day and 90-day mortality rates similar incidence of serious adverse events

Vaso

pres

sin

and

Sept

ic S

hock

Tri

al (

VASS

T)

Russell JA Walley KR Singer J Gordon AC Heacutebert PC Cooper DJ Holmes CL Mehta S Granton JT Storms MM Cook DJ Presneill JJ Ayers D VASST Investigators Vasopressin versus norepinephrine infusion in patients with septic shock N Engl J Med 2008358(9)877

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 37: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressorsbull Annane et al Lancet 2007 370 676ndash84 330 patients with septic shock in

French ICUrsquosbull Titrated to maintain MAP at 70mmHg Primary outcome 28 day mortality

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 38: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

4ANAPHYLACTIC SHOCK

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 39: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

ANAPHYLACTIC SHOCK

Drug of choice Potentially lifesaving

Antagonizes the effects of the released mediators

Maintains blood pressure

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 40: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Hypotension in anaphylaxis is due to a dramatic shift of intravascular volume

bull Fundamental treatment intervention after epinephrine is aggressive IV fluid administration

bull Vasopressors may also be needed to support blood pressure

bull Intravenous epinephrine (110000 vv preparation) can be administered as a continuous infusion especially when the response to intramuscular epinephrine (11000 vv) is poor

bull Dopamine infusion can also be used

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 41: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

ANAPHYLACTIC SHOCK

bull Beta blocked patients or Refractory shock

bull Glucagonbull both inotropic effects and chronotropic effects on the heart by

increasing intracellular levels of cAMP independent of the beta-adrenergic receptors

bull can also reverse bronchospasm

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 42: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

Drug Mechanism Action

Enoximone

milrinone

Phosphodiesterase III (PDE III)

inhibitor prevent hydrolysis of

intracellular cyclic AMP augmenting

its effects Many isoenzymes of

phosphodiesterase ndash PDE III is the

target for inotropic actions

Increased cardiac

contractility and stroke

volume vasodilatation

Levosimendan Calcium sensitizer Increases the

sensitivity of myocardial troponin to

intracellular calcium possible

inhibition of PDE III

Increased cardiac

contractility without

increasing myocardial

oxygen demand effect on

mortality unclear

Vasopressin Endogenous hormone also called

antidiuretic hormone V1 receptor

activity in vascular smooth muscle increasing intracellular calcium

Vasoconstriction increasing

systemic vascular

resistance and blood

pressure

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 43: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

T

UO

Y

KNA

H

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46
Page 44: Rational choice of inotropes and vasopressors in intensive care unit

inotropes vasopressors

httpswwwfacebookcomsaneeshpj

saneeshpjyahoocom

  • Inotropes
  • Slide 2
  • INOTROPES amp VASOPRESSORS
  • Fundamentals
  • Hemodynamics in Shock
  • Hemodynamics in Shock (2)
  • Planning your strategy
  • Adrenergic receptors and vasoactive agents
  • Slide 11
  • Slide 12
  • Slide 13
  • Slide 14
  • How do I make
  • Rationale of choice
  • Rationale of choice (2)
  • Rationale of choice (3)
  • Slide 19
  • Slide 20
  • Decision making
  • Slide 22
  • Slide 23
  • Slide 24
  • Slide 25
  • Slide 26
  • Slide 27
  • Slide 28
  • Slide 29
  • Slide 30
  • Slide 31
  • Slide 32
  • Slide 33
  • Slide 34
  • Slide 35
  • Slide 36
  • Slide 37
  • Slide 38
  • Slide 39
  • Slide 40
  • Slide 41
  • Slide 42
  • Slide 43
  • Slide 44
  • Slide 45
  • Slide 46